Nima Farzan
Director, Keros Therapeutics, Inc.
Companies
- Latigo Biotherapeutics, Inc.Board member Aug 6, 2026 to now1
- Latigo Biotherapeutics, Inc.Chief executive officer Aug 6, 2026 to now1
- Latigo Biotherapeutics, Inc.President Aug 6, 2026 to now1
- Keros Therapeutics, Inc.Board member Apr 7, 2020 to now2
- Kinnate Biopharma Inc.Board member Dec 2, 2020 to Apr 5, 20243
- Kinnate Biopharma Inc.Chief executive officer Dec 2, 2020 to Apr 5, 20243
- Kinnate Biopharma Inc.President Dec 2, 2020 to Dec 2, 20203
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Latigo Biotherapeutics, Inc. LTGO114,453 shares4$1.7M at $14.76Aug 6, 2026
- Keros Therapeutics, Inc. KROS9,767 shares5$108.4K at $11.10Jun 4, 2026
- Kinnate Biopharma Inc.0 shares6Apr 3, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 4, 2026Sold 2,625 shares at $10.73 of Keros Therapeutics, Inc.5
- Jun 3, 2026Granted 7,142 shares of Keros Therapeutics, Inc.7
- Jun 4, 2025Granted 5,250 shares of Keros Therapeutics, Inc.8
- Apr 3, 2024Returned to company 2,186 shares of Kinnate Biopharma Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARKinnate Biopharma Inc., Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 5, 2026
- 8SEC EDGARForm 4 filed Jun 6, 2025